Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoen, B.
Right arrow Articles by Kessler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoen, B.
Right arrow Articles by Kessler, M.

Journal of the American Society of Nephrology, Vol 9, 869-876, Copyright © 1998 by American Society of Nephrology

REGULAR ARTICLES

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients

B Hoen, A Paul-Dauphin, D Hestin and M Kessler
Service de Maladies Infectieuses et Tropicales, University of Nancy Medical Center, Vandoeuvre, France.

Bacteremic infections are a major cause of mortality and morbidity in chronic hemodialysis patients. New developments in managing these patients (erythropoietin therapy, nasal mupirocin, long-term implanted catheters, and synthetic membranes) may have altered the epidemiologic patterns of bacteremia in dialysis patients. This multicenter prospective cross-sectional study was carried out to determine the current incidence of and risk factors for bacteremia in chronic hemodialysis patients in France. A total of 988 adults on chronic hemodialysis for 1 mo or longer was followed up prospectively for 6 mo in 19 French dialysis units. The factors associated with the development of at least one bacteremic episode over 6 mo were determined using the multivariate Cox proportional hazards model. Staphylococcus aureus (n=20) and coagulase-negative staphylococci (n=15) were responsible for most of the 51 bacteremic episodes recorded. The incidence of bacteremia was 0.93 episode per 100 patient- months. Four risk factors for bacteremia were identified: (1) vascular access (catheter versus fistula: RR=7.6; 95% CI, 3.7 to 15.6); (2) history of bacteremia (> or =2 versus no previous episode: RR=7.3; 95% CI, 3.2 to 16.4); (3) immunosuppressive therapy (current versus no: RR=3.0; 95% CI, 1.0 to 6.1); and (4) corpuscular hemoglobin (per 1 g/dl increment: RR=0.7; 95% CI, 0.6 to 0.9). Catheters, especially long-term implanted catheters, were found to be the leading risk factor of bacteremia in chronic hemodialysis patients. There was a trend toward recurrence of bacteremia that was not associated with chronic staphylococcal nasal carriage. Synthetic membranes were not associated with a lower risk of bacteremia in this population of well dialyzed patients, but anemia linked to resistance to erythropoietin appeared to be a possible risk factor for bacteremia.


This article has been cited by other articles:


Home page
 CJASNHome page
S. J. Vandecasteele, J. R. Boelaert, and A. S. De Vriese
Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know
Clin. J. Am. Soc. Nephrol., August 1, 2009; 4(8): 1388 - 1400.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
A. Hayat
Safety Issues With Intravenous Iron Products in the Management of Anemia in Chronic Kidney Disease
Clin. Med. Res., December 1, 2008; 6(3-4): 93 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. T. James, K. B. Laupland, M. Tonelli, B. J. Manns, B. F. Culleton, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network
Risk of Bloodstream Infection in Patients With Chronic Kidney Disease Not Treated With Dialysis
Arch Intern Med, November 24, 2008; 168(21): 2333 - 2339.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
L. S. Dalrymple and A. S. Go
Epidemiology of Acute Infections among Patients with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1487 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
S. Baroudi, R. A. Qazi, K. L. Lentine, and B. Bastani
Infective endocarditis in haemodialysis patients: 16-year experience at one institution
NDT Plus, August 1, 2008; 1(4): 253 - 256.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Ishani, C. A. Solid, E. D. Weinhandl, D. T. Gilbertson, R. N. Foley, and A. J. Collins
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1682 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. Labriola, R. Crott, and M. Jadoul
Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1666 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
P. Beris, M. Munoz, J. A. Garcia-Erce, D. Thomas, A. Maniatis, and P. Van der Linden
Perioperative anaemia management: consensus statement on the role of intravenous iron
Br. J. Anaesth., May 1, 2008; 100(5): 599 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Ponticelli
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 27 - 32.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Trzonkowski, A. Debska-Slizien, A. Mysliwski, and B. Rutkowski
Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patients
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3221 - 3227.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
L. Maynor and D. F Brophy
Risk of Infection with Intravenous Iron Therapy
Ann. Pharmacother., September 1, 2007; 41(9): 1476 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C.-H. Chen, W.-H. Hsu, H.-J. Chen, W. Chen, C.-M. Shih, T.-C. Hsia, and C.-Y. Tu
Different Bacteriology and Prognosis of Thoracic Empyemas Between Patients With Chronic and End-Stage Renal Disease
Chest, August 1, 2007; 132(2): 532 - 539.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
P.C. Thomson, C.M. Stirling, C.C. Geddes, S.T. Morris, and R.A. Mactier
Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death
QJM, July 1, 2007; 100(7): 415 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. Kamalakannan, R. M. Pai, L. B. Johnson, J. M. Gardin, and L. D. Saravolatz
Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients
Ann. Thorac. Surg., June 1, 2007; 83(6): 2081 - 2086.
[Abstract] [Full Text] [PDF]

Home page
 pdiHome page
D. W. Johnson
INTRAVENOUS VERSUS ORAL IRON SUPPLEMENTATION IN PERITONEAL DIALYSIS PATIENTS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S255 - S260.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. Gupta, L. C. Plantinga, N. E. Fink, M. L. Melamed, J. Coresh, C. S. Fox, N. W. Levin, and N. R. Powe
Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
JAMA, April 4, 2007; 297(13): 1455 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
O. Johnston, N. Zalunardo, C. Rose, and J. S. Gill
Prevention of Sepsis during the Transition to Dialysis May Improve the Survival of Transplant Failure Patients
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1331 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. H. Horl
Clinical Aspects of Iron Use in the Anemia of Kidney Disease
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 382 - 393.
[Full Text] [PDF]

Home page
 CJASNHome page
N. Aslam, J. Bernardini, L. Fried, R. Burr, and B. Piraino
Comparison of Infectious Complications between Incident Hemodialysis and Peritoneal Dialysis Patients
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1226 - 1233.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Guz, G. L. Glorieux, R. De Smet, M.-A. F. Waterloos, R. C. Vanholder, and A. W. Dhondt
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2834 - 2840.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. J. Fadrowski, W. Hwang, D. L. Frankenfield, B. A. Fivush, A. M. Neu, and S. L. Furth
Clinical Course Associated with Vascular Access Type in a National Cohort of Adolescents Who Receive Hemodialysis: Findings from the Clinical Performance Measures and US Renal Data System Projects
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 987 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
U. S. Nori, A. Manoharan, J. I. Thornby, J. Yee, R. Parasuraman, and V. Ramanathan
Mortality risk factors in chronic haemodialysis patients with infective endocarditis
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2184 - 2190.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. K. Inrig, S. D. Reed, L. A. Szczech, J. J. Engemann, J. Y. Friedman, G. R. Corey, K. A. Schulman, L. B. Reller, and V. G. Fowler Jr.
Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 518 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton
CHAPTER 4: Vascular Access
J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S16 - S23.
[Full Text] [PDF]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
H. E. Rodriguez, L. Leon, P. Schalch, N. Labropoulos, M. Borge, and P. G. Kalman
Arteriovenous Access: Managing Common Problems
Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2005; 17(2): 155 - 166.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Allon, M. Radeva, J. Bailey, S. Beddhu, D. Butterly, D. W. Coyne, T. A. Depner, J. J. Gassman, A. M. Kaufman, G. A. Kaysen, et al.
The spectrum of infection-related morbidity in hospitalized haemodialysis patients
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1180 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Cappelli, C. Tetta, and B. Canaud
Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis
Nephrol. Dial. Transplant., February 1, 2005; 20(2): 266 - 270.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. R. Aronoff
Safety of Intravenous Iron in Clinical Practice: Implications for Anemia Management Protocols
J. Am. Soc. Nephrol., December 1, 2004; 15(suppl_2): S99 - S106.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. D. C. Duncan, S. Singh, T. D. H. Cairns, M. Clark, A. El-Tayar, M. Griffith, N. Hakim, M. Hamady, A. G. McLean, V. Papalois, et al.
Tesio-Caths provide effective and safe long-term vascular access
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2816 - 2822.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. E. Lockhart, M. L. Robbin, M. M. McNamara, and M. Allon
Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients
Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2564 - 2569.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Ottonello, P. Gnerre, M. Bertolotto, M. Mancini, P. Dapino, R. Russo, G. Garibotto, T. Barreca, and F. Dallegri
Leptin as a Uremic Toxin Interferes with Neutrophil Chemotaxis
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2366 - 2372.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. J. Oliver, D. M. Rothwell, K. Fung, J. E. Hux, and C. E. Lok
Late Creation of Vascular Access for Hemodialysis and Increased Risk of Sepsis
J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1936 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Hoen
Infective endocarditis: a frequent disease in dialysis patients
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1360 - 1362.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
H. I. Feldman, M. Joffe, B. Robinson, J. Knauss, B. Cizman, W. Guo, E. Franklin-Becker, and G. Faich
Administration of Parenteral Iron and Mortality among Hemodialysis Patients
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1623 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. N. Foley, H. Guo, J. J. Snyder, D. T. Gilbertson, and A. J. Collins
Septicemia in the United States Dialysis Population, 1991 to 1999
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1038 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Van Wyck, J. Anderson, and K. Johnson
Labile iron in parenteral iron formulations: a quantitative and comparative study
Nephrol. Dial. Transplant., March 1, 2004; 19(3): 561 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Boure and R. Vanholder
Which dialyser membrane to choose?
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 293 - 296.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. Sengoelge, J. Kletzmayr, I. Ferrara, A. Perschl, W. H. Horl, and G. Sunder-Plassmann
Impairment of Transendothelial Leukocyte Migration by Iron Complexes
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2639 - 2644.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Allon, T. A. Depner, M. Radeva, J. Bailey, S. Beddhu, D. Butterly, D. W. Coyne, J. J. Gassman, A. M. Kaufman, G. A. Kaysen, et al.
Impact of Dialysis Dose and Membrane on Infection-Related Hospitalization and Death: Results of the HEMO Study
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1863 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
V. Mickley
Surgical alternatives to central venous catheters in chronic renal replacement therapy
Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1045 - 1051.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly
Hemodialysis Infection Prevention with Polysporin Ointment
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Fernandez-Cean, A. Alvarez, S. Burguez, G. Baldovinos, P. Larre-Borges, and M. Cha
Infective endocarditis in chronic haemodialysis: two treatment strategies
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2226 - 2230.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
W. Van Biesen, N. Veys, R. Vanholder, and N. Lameire
Peritoneal-dialysis-related peritonitis: the art of rope-dancing
Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1878 - 1882.
[Full Text] [PDF]

Home page
 PediatricsHome page
N. P. O'Grady, M. Alexander, E. P. Dellinger, J. L. Gerberding, S. O. Heard, D. G. Maki, H. Masur, R. D. McCormick, L. A. Mermel, M. L. Pearson, et al.
Guidelines for the Prevention of Intravascular Catheter-Related Infections
Pediatrics, November 1, 2002; 110(5): e51 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
V. Mickley
Central venous catheters: many questions, few answers
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1368 - 1373.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Butterly and S. J. Schwab
The Case Against Chronic Venous Hemodialysis Access
J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2195 - 2197.
[Full Text] [PDF]

Home page
 QJMHome page
S.J. Peacock, S. Mandal, and I.C.J.W. Bowler
Preventing Staphylococcus aureus infection in the renal unit
QJM, June 1, 2002; 95(6): 405 - 410.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
H. I. Feldman, J. Santanna, W. Guo, H. Furst, E. Franklin, M. Joffe, S. Marcus, and G. Faich
Iron Administration and Clinical Outcomes in Hemodialysis Patients
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 734 - 744.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. J. Sarnak and B. L. Jaber
Pulmonary Infectious Mortality Among Patients With End-Stage Renal Disease
Chest, December 1, 2001; 120(6): 1883 - 1887.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. J. Blankestijn
Treatment and prevention of catheter-related infections in haemodialysis patients
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1975 - 1978.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Parkkinen, L. von Bonsdorff, S. Peltonen, C. Gronhagen-Riska, and K. Rosenlof
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration
Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1827 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. H. MOKRZYCKI, B. SCHRÖPPEL, G. V. GERSDORFF, H. RUSH, M. P. ZDUNEK, and R. FEINGOLD
Tunneled-Cuffed Catheter Associated Infections in Hemodialysis Patients Who Are Seropositive for the Human Immunodeficiency Virus
J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2122 - 2127.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
S. Fishbane, J. K. Maesaka, and S. K. Mittal
Is there material hazard to treatment with intravenous iron?
Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2595 - 2598.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Canaud
Haemodialysis catheter-related infection: time for action
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2288 - 2290.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. BESARAB, S. FRINAK, and J. YEE
An Indistinct Balance: The Safety and Efficacy of Parenteral IronTherapy
J. Am. Soc. Nephrol., September 1, 1999; 10(9): 2029 - 2043.
[Full Text]

Home page
 Nephrol Dial TransplantHome page
K. Iseki, M. Tozawa, S. Yoshi, and K. Fukiyama
Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1956 - 1960.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. Z. MA, J. EBBEN, H. XIA, and A. J. COLLINS
Hematocrit Level and Associated Mortality in Hemodialysis Patients
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 610 - 619.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. W. Adamson and J. W. Eschbach
Erythropoietin for End-Stage Renal Disease
N. Engl. J. Med., August 27, 1998; 339(9): 625 - 627.
[Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673